Chapter 17: Hematologic and Immune Disorders

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Usually when we talk about a medical diagnosis, there's this underlying expectation of precision, like engineering.

Right.

Yeah, like it's a very straightforward binary thing.

Exactly.

If a patient breaks their arm, the x -ray shows that jagged white line and the doctor just points at the screen and says, well, there it is.

That's the problem.

Which is,

psychologically, that's incredibly comforting for everyone involved.

We really like our threats to be visible.

But the second you step into the world of critical care, and specifically when you start dealing with the hematologic and immune systems,

that comforting x -ray machine becomes entirely useless.

Completely useless.

Yeah.

We are suddenly looking at a microscopic cellular landscape that is just chaotic.

If a patient's immune system turns on them or their clotting cascade goes rogue, they can literally clot to death and bleed to death at the exact same time.

It is the absolute definition of diagnostic muddy waters.

But you know, it's also the total foundation of critical care survival.

Right, because everything relies on it.

Exactly.

I mean, you cannot stabilize a critically ill patient if their blood simply cannot carry oxygen or if their immune system can't fight off a secondary infection.

So it doesn't even matter what brought them into the ICU in the first place.

No, not really.

Regardless of the primary injury, they almost always experience some level of disruption in their hematologic or immune function.

You will see this at the bedside.

Which is exactly why we are focusing entirely on these systems for today's deep dive.

So if you are listening to this, you are likely a college nursing student and well, we have a very specific mission for you today.

Very targeted mission.

Yeah.

Think of this as a personalized one -on -one tutoring session.

We aren't just going to, you know, read chapter 17 of Introduction to Critical Care Nursing at you.

No, nobody wants that.

Definitely not.

Instead, we're going to build a logical physiological chain.

We'll start with how the body is supposed to work, walk what happens when that system collapses, and then figure out exactly what you need to do to save that patient's life.

And that logical chain, it really has to start at the source, the factory essentially.

Yes, the bone marrow.

I always picture the bone marrow, which by the way is hiding out in the pelvis, ribs, vertebrae, and the skull as this massive, relentless manufacturing plant.

That is the perfect analogy for it.

And the raw material that this plant uses is the pluripotent hematopoietic stem cell.

I mean, every single blood component starts as this one versatile cell.

It's totally wild.

Depending on what the body needs at that exact moment, that pluripotent stem cell differentiates into one of three main product lines.

Okay.

Lay them out for us.

So you have your erythrocytes, which are the red blood cells, you have your leukocytes, the white blood cells, and you have your thromocytes, the platelets.

But what absolutely blows my mind, like when you really look at it, is the massive difference in the lifespans of these manufactured products.

Oh, the contrast is staggering.

It dictates everything about how a patient crashes.

Right.

Because red blood cells, they stick around for a while.

They are like the long haul delivery trucks.

But the white blood cells.

Yeah.

A red blood cell has a lifespan of roughly 120 days.

Your white blood cells,

specifically the neutrophils, whose entire job is to fight off bacterial infections.

They circulate in the blood for less than 24 hours.

Wow.

Just one day.

And if your patient has a severe active infection, those neutrophils are working so hard to eat or phagocytize the invading bacteria that their lifespan drops to literally just a few hours.

Wait, a few hours?

So if that bone marrow manufacturing plant goes offline for any reason, like chemotherapy, radiation, or a bone marrow failure,

the patient loses their immune defense almost instantly.

Precisely.

You lose the neutrophils immediately.

The red blood cells might hang on for a few weeks, but your security force is wiped out by dinnertime.

That is terrifying.

Okay.

So the bone marrow is the primary factory.

But we also have to understand the secondary organs involved here, right?

Yeah, you really do.

We are talking about the spleen, the thymus, the lymph nodes, and crucially, the liver.

Okay.

I have to stop you there because this is a connection that trips a lot of people up.

When we think of the liver, we think of, I don't know, digestion, alcohol metabolism, maybe jaundice.

Right, the GI stuff.

Yeah.

So why is a GI organ so critical to the blood and immune system?

It is a massive piece of the puzzle.

If you look at Fig.

17 -2 in the text, it shows how the liver acts as a high -volume filter for the blood.

It's constantly clearing out debris.

Okay, so it's a filter.

It is.

And it also breaks down old red blood cells to create bile.

But its absolute most vital hematologic function is production.

The liver is the sole manufacturing site for a huge portion of your body's circulating clotting factors.

Oh, wow.

So a failing liver isn't just a filtration problem.

Not at all.

If the liver shuts down, the factory making the clotting factors goes dark, which means this patient is now an immediate massive bleeding hazard.

Exactly.

Liver failure leads directly to profound coagulopathies and metabolic chaos.

They simply cannot form a stable clot without those hepatic factors.

That makes perfect sense.

And, you know, we also have to recognize that this whole system,

the marrow, the liver, the immune response, it doesn't operate at the exact same capacity for every patient.

No, age and demographics play a huge role.

Because you cannot assess a 25 -year -old trauma patient the exact same way you assess an 85 -year -old with pneumonia.

The elderly just don't have the same physiological reserves.

They really don't.

As we age, the actual percentage of marrow space occupied by active blood producing tissue, it just decreases.

So the factory literally shrinks.

Exactly.

And on top of that, an older patient has decreased T cell function and altered immunoglobulin levels.

So their immune response is super sluggish, making them highly susceptible to secondary infections in the ICU.

And then on the other end of the spectrum, pregnant patients face totally unique hematologic risks, don't they?

Oh, absolutely.

They can develop gestational thrombocytopenia, which is a dangerous drop in platelet.

Or that really severe one, H -E -L -L -P syndrome, right?

Yes, H -E -L -L -P syndrome,

which stands for hemolysis, elevated liver enzymes, and low platelet count.

It is basically a perfect storm of red blood cell destruction and liver distress.

So as the nurse, you have to anticipate these specific lifespan alterations the second you walk into the room.

You do.

Which brings us to the most important part of your job,

really, detecting the threat.

Right.

Because how do you actually assess a patient when these microscopic systems start to fail?

Well, you do your physical assessment.

You look at the skin.

Table 17 -5 lays this out perfectly.

If the platelets are failing or the clotting factors are gone, you are going to see visual evidence of capillary rupture.

But we need to be precise with our clinical terminology here.

We aren't just looking for bruises.

No, you're looking for petechiae.

Those are the tiny,

pinpoint, non -elevated red or purple dots on the skin.

And those are usually the first sign.

Yeah.

They are often the very first sign of a critically low platelet count.

Now, if those tiny dots pool together into larger, mottled, purplish areas, we call that purpura.

Okay.

Petechiae are the dots, purpura is the mottled areas.

And what about ecchymosis?

Ecchymosis is the clinical term for your classic larger bruise where a significant amount of blood has pooled under the tissue.

Got it.

But here is where the assessment gets truly terrifying, especially for a new critical care nurse.

The visual cues aren't always there.

No, they aren't.

And this is a massive safety priority.

Right.

Like, if a patient is severely immunocompromised, let's say they have absolute neutropenia following chemotherapy,

they experience what we call a blunted response.

This is perhaps the most critical concept in immune disorders.

All those classic signs of infection, the redness at the IV site, the swelling, the

Yeah.

Those are not actually created by the bacteria.

Those symptoms are created by your own white blood cells rushing to the area to fight the bacteria.

Oh, wow.

So if you have no white blood cells.

You have no redness, no swelling, nothing.

That is wild.

Even in the face of a severe life -threatening systemic infection, your patient might not even mount a fever.

Exactly.

They simply do not have the cellular soldiers required to trigger that inflammatory alarm system.

That means you can't rely on the obvious visual cues at all.

You might just see a very subtle shift in their mental status or like a slight unexplained tachycardia.

And if you miss it, they go straight into septic shock.

So if the physical assessment is blunted, we have to look at the invisible data.

We have to decode the labs.

Let's talk about tables 17 to 6 and 17 to 7.

The coagulation profile.

Understanding a coag profile is all about knowing which specific pathway of the clotting cascade you are measuring.

We primarily look at two times.

The prothrombin time, or PT, and the activated partial thromboplastin time, or APTT.

Right.

Okay, so if I'm at the bedside, I'm using these two different alarms for two different clinical situations.

If my patient's taking warfarin, I'm hyper -focused on the PT because the PT evaluates the extrinsic coagulation pathway.

Spot on.

But if I have a patient on a continuous heparin drip, I am watching the APT like a hawk because that evaluates the intrinsic pathway.

You nailed it.

And alongside those, you also need to monitor fibrin degradation products, or FTPs, and the D -dimer.

Now, wait, those aren't measuring the ability to clot, right?

They measure clot breakdown?

Exactly.

When a clot has done its job, the body uses an enzyme called plasmin to dissolve it.

And when that clot dissolves, it leaves behind microscopic fragments.

So high levels of FTPs or a heavily elevated D -dimer, what does that tell you?

It tells you that the body is actively and aggressively breaking down massive amounts of clots somewhere in the vascular system, which is a huge red flag.

A red flag that we are definitely going to dive into when we talk about DIC.

But first, let's follow the physiological cascade.

Let's look at what happens when specific components of the blood fail.

Let's start with the erythrocytes, the red blood cells.

Right.

When they fail, you have anemia.

And the pathophysiology of anemia is just a very straightforward, brutal cause and effect.

Anemia is simply a reduction in circulating red blood cells or the hemoglobin inside them.

And since hemoglobin is the oxygen carrier, when hemoglobin drops, oxygen delivery drops.

The tissues become hypoxic.

But the human body doesn't just sit there and accept tissue hypoxia.

It fights back.

There is this fascinating biochemical switch called 2 -H3 -DPG.

Yes, 2 -H3 -diphosphoglycerate.

Can you translate that dense biochemical term into practical nursing knowledge?

What does it actually do?

When tissues are starving for oxygen, they produce higher concentrations of 2 -H3 -DPG.

This molecule physically binds to the circulating hemoglobin and acts as a signal.

A signal to do what?

It forces the hemoglobin to alter its structural shape, which drastically decreases its affinity for oxygen.

Meaning the hemoglobin can't hold onto the oxygen as tightly?

Exactly.

It essentially forces the delivery trucks to kick their cargo on the door right into the starting tissues.

It optimizes oxygen unloading.

That's brilliant.

And while that's happening at the cellular level, the heart compensates macroscopically, right?

Yeah.

The heart rate shoots up tachycardia to circulate whatever oxygen is left as fast as possible.

Plus the body shunts blood away from the skin and gut to protect the brain and the heart.

Which perfectly explains why a severely anemic patient is tachycardic, pale, and cold to the touch.

But the root cause of the anemia actually changes how you treat it.

It really does.

For example, in a plastic anemia, the bone marrow factory just shuts down completely.

Nothing is being made.

But hemolytic anemia is entirely different.

Right.

In hemolytic anemia, the factory is working fine.

But the red blood cells are being actively destroyed or ruptured in the bloodstream faster than they can be replaced.

And because all those ruptured cells release their contents, you see specific clinical signs like profound jaundice from the excess bilirubin.

Yes.

And an enlarged spleen because it's working overtime to clear all that dead cellular debris.

And then you have sickle cell anemia.

This is where a genetic mutation causes the red blood cells to literally change shape into a rigid sickle when oxygen levels drop.

And those rigid cells clump up.

They cause massive sluggish traffic jams, the microvasculature.

Which is agonizingly painful, right?

It causes severe joint pain and tissue ischemia.

If those sickled cells block the blood flow to the kidneys,

the patient develops acute uremia because the kidneys simply can't filter waste anymore.

So if a patient is severely anemic,

regardless of the cause, I think the instinct is just to give them blood, give them a transfusion.

That's the natural thought, yes.

But the evidence -based practice box in the text actually tells us to pump the brakes on that.

This is a massive shift in critical care thinking.

Historically, the standard was to transfuse a patient as soon as their hemoglobin dropped to like 10 grams per deciliter.

But not anymore.

No.

Current evidence shows that a more restrictive threshold waiting until the hemoglobin drops below 7 or 8 is actually far safer.

Wait, why if they are low on blood, why is withholding blood the safer option?

Because a blood transfusion is essentially a liquid organ transplant.

It triggers a massive inflammatory response.

The evidence overwhelmingly shows that liberal transfusion strategies significantly increase the risk of acute lung injury, volume overload, and overall mortality.

Yeah, unless the patient is actively hemorrhaging or showing severe ischemic symptoms,

less is definitely more.

That is such a vital bedside takeaway.

Okay, moving down our product line, we've covered the red blood cell failures.

Now let's pivot to the white blood cells and the immunocompromised patient.

Let's talk about neutropenia.

Diagnostically, this is defined as an absolute neutrophil count, or ANC, below 1500 per microliter.

But as a nurse, you don't just wait for the lab to calculate that, right?

No, you really need to understand where that number comes from.

So how do we calculate it?

Walk us through the formula from the text.

Okay, you take the total white blood cell count, then you look at your differential to find the percentage of mature neutrophils, which we call segs, and the percentage of immature neutrophils called bands.

Segs and bands.

Got it.

You add those two percentages together and multiply that by your total white blood cell count times 100.

That gives you your absolute number of capable soldiers.

And once that ANC drops below 1500, your nursing interventions have to shift drastically.

The care plan box is super clear about this.

The patient has no defense.

Not at all.

So you are implementing strict hand washing, you are providing meticulous mouth care to prevent mucosal breakdown, and you are literally banning fresh flowers and standing water from the room.

Which sounds incredibly strict to families.

Like, why no flowers?

Yeah, people always ask that.

It's because the water in a flower vase is a breeding ground for bacteria like Pseudomonas.

To a healthy person, Pseudomonas is harmless.

But to a patient with an ANC of 500, it is a lethal pathogen.

So protecting a neutropenic patient is like running a clean room in a microchip factory.

Literally every single environmental variable is a lethal threat.

That is the exact mentality you must adopt.

Now this level of amino compromise is often seen in malignancies, and Table 1710 details three specific blood cancers you need to differentiate.

First up, leukemia.

Right.

In leukemia, the bone marrow goes rogue and starts mass producing entirely immature, dysfunctional white blood cells.

They just crowd out everything else.

Exactly.

So the patient has no real immunity, plus they develop anemia and bleeding because the factory floor is just overrun with useless products.

Then you have lymphoma, which is characterized by solid tumors developing within the lymphoid tissue itself.

Clinically, this often presents as painless, enlarged lymph nodes.

But the third one,

multiple myeloma, that one is unique and devastating.

Because it's a malignancy of the plasma cells, right?

Yes.

And these malignant plasma cells secrete abnormal antibodies.

Specifically, these structures called Benz -Jones proteins.

And you find those spilling directly into the patient's urine.

That is a classic diagnostic hallmark you have to remember.

But the truly terrifying part of multiple myeloma is what it does to the skeletal structure.

These malignant cells aggressively destroy bone tissue.

And as the bone breaks down, all that stored calcium leaches directly into the bloodstream.

So the patient isn't just dealing with cancer.

They're experiencing agonizing bone pain and critical hypercalcemia.

Which can trigger lethal cardiac arrhythmias.

It's just a cascading failure.

It really is.

Now, immune failure isn't always cancer.

Sometimes it's viral, like with HIV.

HIV specifically targets the CD4 T cells, which are basically the commanding officers of the immune system.

And the crucial clinical threshold you need to know here is a CD4 count below 200 cells per microliter.

Because that specific number marks the physiological transition from an HIV infection to the active AIDS.

Exactly.

At a CD4 count of 200, the commanding officers are virtually gone.

The immune system is flying blind.

And that is when your nursing priority must shift to aggressive monitoring for opportunistic infections.

Things that would never take root in a healthy host.

Like pneumocystis pneumonia.

Yeah.

All right.

Take a breath.

We've covered the oxygen carriers and the security force.

We are now heading into the most intense, high -stakes part of critical care.

The bleeding disorders.

The coagulopathies.

Yes.

Specifically, heparin -induced thrombocytopenia and DIC.

Let's start with box 17 to 5, HIT.

HIT is a fascinating and terrifying paradox.

Heparin is an anticoagulant.

We give it to prevent clots.

But in a subset of patients, exposure to heparin triggers an aggressive immune response.

The body forms antibodies that bind to complexes on the platelets.

And this causes a rapid drop in the platelet count, right?

Usually plummeting by 50 % or more within days.

Yes.

So, logically, if the platelets drop that drastically, the patient should bleed out.

That would make sense.

But that's the paradox.

They don't just bleed.

Those antibodies actually activate the remaining platelets.

The platelets go into an absolute frenzy.

The patient experiences severe, paradoxical, widespread clotting.

Thrombosis.

Exactly.

They develop deep vein thrombosis, pulmonary embolisms, or massive arterial clots that cut off blood flow to entire limbs.

That is wild.

The very drug you gave to thin the blood causes systemic lethal clotting while simultaneously wiping out the platelet count.

Which means the absolute first nursing action is to instantly stop all heparin exposure.

Even the heparin flushes for IDs.

You stop it all and switch the patient to a direct thrombin inhibitor.

Which leads us directly into a condition that sounds somewhat similar but operates on an entirely different scale of destruction.

Disseminated Intravascular Coagulation, DIC.

The Ultimate Consumption Coagulopathy.

Yeah, let's get into it.

DIC is the nightmare scenario.

And it's crucial to understand that DIC is never a primary disease.

It is always a secondary complication triggered by a massive systemic insult.

Like severe septic shock, massive multi -system trauma, or extensive burns.

Exactly.

Let me see if I can trace the pathology of this because it's incredibly complex.

The initial insult, let's say massive trauma, causes widespread endothelial damage to the blood vessels.

Yes, profound tissue destruction.

And this inappropriately triggers the coagulation cascade on a systemic whole body level.

The body essentially hits the panic button.

Right.

So the patient's microvasculature, the hundreds of thousands of tiny capillaries all over their body, suddenly start clotting uncontrollably.

They are throwing thousands of microscopic clots everywhere.

And this is exactly where the consumption aspect comes in.

Because of this widespread, inappropriate microscopic clotting, all of the body circulating clotting factors, all of the fibrinogen and all of the platelets are rapidly consumed.

The factory reserves are completely used up in minutes.

Yes.

And the consequence of using up all the factors on these microquots is that the patient loses the ability to clot anywhere else.

So they begin to massively uncontrollably hemorrhage from every single orifice.

From their 5E insertion sites, from their gums, and deep into their internal cavities.

They are literally clotting to death and bleeding to death at the exact same time.

And if you look at their labs, it perfectly reflects this chaos.

How so?

Well, the platelets and fibrinogen are critically low because they have been consumed.

The PT and APTT are profoundly prolonged because the patient is actively hemorrhaging without any factors to stop it.

And the D -dimer.

Oh, it'll be sky high.

Because the body's plasmid system is frantically trying to break down those thousands of microclots, you will see highly elevated fibrin degradation products and a massive D -dimer.

Okay, here is where I have to push back based on the text.

A patient is actively bleeding out of their eyeballs, essentially.

And some protocols suggest we might administer a continuous heparin drip.

I know.

How does giving a powerful blood thinner to a hemorrhaging patient make any physiological sense?

It sounds completely insane, but you have to go back to the root mechanism.

The systemic hemorrhage is only happening because the clotting factors are being consumed by that runaway microvascular clotting cascade.

Oh, I see.

So, in highly specific, closely monitored situations, low -dose heparin is administered to stop that initial inappropriate microvascular clotting.

Wait, really?

So, if you can halt the abnormal clotting cascade, you halt the consumption.

Exactly.

You give the liver time to catch up, manufacture new clotting factors, and eventually stop the macroscopic hemorrhage.

You are treating the microscopic root cause to fix the macroscopic bleeding.

That is brilliant, but absolutely terrifying.

It requires extreme caution because the margin of error is basically zero.

Oh, it's highly controversial and requires meticulous titration.

It's the ultimate test of critical care judgment.

So when a patient is in DIC, or severe liver failure, and they're bleeding out, how do we fix the deficit?

We have to know exactly what blood products to hang on the IV pole.

Let's look at Table 1711.

Right.

You can't just hang whole blood and hope for the best.

The nurse must match the product to the specific physiological deficit.

Okay, so if the patient has a circulating oxygen deficit, meaning severe symptomatic anemia,

what do we hang?

You administer packed red blood cells, or PRBCs.

That replaces the delivery trucks.

What if their platelet count has tanked from severe thrombocytopenia?

Then you administer a platelet transfusion to restore the initial platelet plug function.

And what if the patient is bleeding because they have prolonged PT and ABT times, meaning they're missing the actual clotting factors, like in liver failure or DIC?

In that case, you must administer fresh frozen plasma, or FFP.

FFP replaces those circulating clotting factors.

And there's one more highly specific product.

What if their fibrinogen level specifically is critically low, like under 100 milligrams per deciliter?

If it's a specific hypofibrinogenemia,

you administer cryoprecipitate.

Cryo is essentially a highly concentrated dose of just fibrinogen and factor VIII.

It is a targeted strike.

And as the nurse hanging these products, you reinforce the safety priorities naturally.

You are the absolute final safety check.

The margin for error here is zero.

You must meticulously verify ABO compatibility,

ensure you are using the correct microaggregate filters for the specific product, and remain vigilantly at the bedside.

You're monitoring for fluid overload or acute transfusion reactions, right?

You're watching for that sudden fever, chills, a rash, or acute respiratory distress.

Because knowledge is only valuable when it is understood and applied safely.

Memorizing what FFP stands for isn't enough.

You have to intuitively understand why you are giving it, and what immediate physiological response you expect to see on the monitor.

Which perfectly encapsulates the entire mission of today's deep dive.

Exactly.

As we wrap up this tutoring session, I want to remind you that memorizing critical care nursing isn't about rote flashcards.

It's about understanding the cascade of events.

It really is all one continuous logical chain.

When you understand normal hemostasis, you intuitively understand why DIC happens.

And that leads you straight to the correct laboratory interpretations and interventions.

Right.

And to test your grasp on those connections, I want to leave you with a final thought exercise straight from the chapter's final case study.

Oh, about Mr.

F.

Let's hear it.

Imagine Mr.

F.

He's a 62 -year -old man with leukemia.

To save his life, he underwent a bone marrow transplant.

But now, he presents with severely dry eyes, a rash, and weight loss.

These are the classic signs of chronic graft -versus -host disease, or GVHD.

Yes.

The new marrow is attacking him.

So ask yourself this, how do the very treatments we use to save a patient's life essentially create an entirely new hostile immune system that attacks the patient's own body?

That is heavy.

What is the critical care nurse's priority when the cure becomes the disease?

That is a phenomenal, provocative question to mull over.

The diagnostic muddy waters aren't just found in the pathology of the disease.

Sometimes they are created by our own treatments.

Thank you so much for listening today.

On behalf of the Last Minute Lecture team, keep asking why, keep pushing for that deeper understanding, and we'll catch you next time on the Deep Dive.